Indicators

Markets:

News

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

...

5 6 7 8 9 10 11 12 Next >

Pfizer moves forward with once-daily version of weight loss pill after setbacks

July 11, 2024

Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'

July 10, 2024

FTC to sue drug middlemen over prices of medications including insulin

July 10, 2024

CNBC Daily Open: French left-wing shock victory, Boeing guilty plea

July 08, 2024

CNBC Daily Open: French far-right advance blocked

July 07, 2024

This ETF is trying to satisfy appetites for weight loss stocks

July 06, 2024

Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition

July 04, 2024

Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial

July 03, 2024

Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data

June 26, 2024

5 things to know before the stock market opens

June 25, 2024

Novo Nordisk's Wegovy weight loss drug approved in China

June 25, 2024

Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic

June 24, 2024

Weight loss drug contender Zealand Pharma jumps 23% on trial results

June 21, 2024

Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss

June 18, 2024

How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi

June 17, 2024

European stocks set for muted open after European Central Bank cut

June 07, 2024

Why half of all workers may struggle to get weight-loss drug health insurance coverage

May 30, 2024

Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages

May 29, 2024

Cramer's Lightning Round: Apple is a buy

May 28, 2024

This new weight loss drug ETF bets big on two of the industry's leading players

May 27, 2024

How digital health companies are capitalizing on the GLP-1 boom

May 25, 2024

Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins

May 21, 2024

AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines

May 21, 2024

Hims & Hers Health adds compounded GLP-1 injections to weight loss program

May 20, 2024

Roche says weight loss drug shows promising results in early trial

May 16, 2024

Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says

May 14, 2024

People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says

May 14, 2024

Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply

May 07, 2024

Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance

May 07, 2024

Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide

May 03, 2024

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.